Skip to main content
رجوع
SVRA logo

Savara Inc.

جودة البيانات: 100%
SVRA
NASDAQ Healthcare Biotechnology
KWD 5.28
▲ KWD 0.24 (4.76%)
القيمة السوقية: 1.08B
نطاق اليوم
KWD 4.90 KWD 5.37
نطاق 52 أسبوعًا
KWD 1.89 KWD 7.01
حجم التداول
1,647,528
متوسط 50 يوم / 200 يوم
KWD 5.61 / KWD 4.23
الإغلاق السابق
KWD 5.04

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E -9.1 0.2
P/B 5.3 3.0
ROE % -63.5 3.6
Net Margin % 3.8
Rev Growth 5Y % 9.9
D/E 0.2 0.2

السعر المستهدف للمحللين

Hold
KWD 10.25 +94.1%
Low: KWD 10.00 High: KWD 11.00
ربحية السهم المستقبلية
-KWD 0.47
الإيرادات المقدّرة
16.55M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 0.75
KWD 0.48 – KWD 1.07
430.12M 1
FY2029 KWD 0.43
KWD 0.28 – KWD 0.62
300.50M 1
FY2028 KWD 0.05
-KWD 0.02 – KWD 0.20
166.50M 5

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2025-11-12 -KWD 0.13 -KWD 0.14 -7.7%
2025-08-13 -KWD 0.12 -KWD 0.14 -16.7%
2025-05-13 -KWD 0.12 -KWD 0.12 0.0%
2025-03-27 -KWD 0.11 -KWD 0.13 -18.2%
2024-11-12 -KWD 0.11 -KWD 0.11 0.0%
2024-08-12 -KWD 0.11 -KWD 0.12 -9.1%
2024-05-09 -KWD 0.10 -KWD 0.11 -10.0%
2024-03-07 -KWD 0.11 -KWD 0.09 +18.2%

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

النقاط الرئيسية

Debt/Equity of 0.15 — conservative balance sheet
Negative free cash flow of -101.06M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-63.45%
ROIC-39.76%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
0.15
Current Ratio11.85
Interest Coverage0.00

التقييم

P/E Ratio
-9.09
Forward P/EN/A
P/B Ratio5.32
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -118.84M
ROE -63.45% ROA -46.89%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -101.06M
ROIC -39.76% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.15 Current Ratio 11.85
Interest Coverage 0.00
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -9.09 Forward P/E N/A
P/B Ratio 5.32 P/S Ratio N/A
PEG Ratio -1.08 Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 65.30 Fwd Earnings Yield N/A
FCF Yield -9.35%
Market Cap 1.08B Enterprise Value 1.08B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 0.0 0.0 0.0 0.0
Net Income -118.84M -95.88M -54.70M -38.15M -43.01M
EPS (Diluted) -0.53 -0.48 -0.33 -0.25 -0.32
Gross Profit -245,000.0 -78.03M -44.26M -27.88M -28.99M
Operating Income -123.55M -103.20M -60.01M -38.84M -41.48M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 253.44M 212.88M 177.56M 139.78M 176.60M
Total Liabilities 50.30M 41.43M 37.19M 32.00M 32.10M
Shareholders' Equity 203.13M 171.45M 140.37M 107.78M 144.50M
Total Debt 29.91M 26.74M 26.49M 26.14M 25.79M
Cash & Equivalents 33.18M 15.13M 26.59M 52.10M 34.01M
Current Assets 241.62M 202.14M 165.95M 128.95M 165.00M
Current Liabilities 20.40M 14.72M 10.60M 5.87M 14.66M